Medical News

RSS

BIOCIUS and Agilent launch RF360 High Resolution System for high-throughput screening of in vitro ADME assays

BIOCIUS Life Sciences, Inc. and Agilent Technologies Inc. today announced the launch of the RF360 High Resolution System for high-throughput screening of in vitro ADME assays. Combining the accurate mass capabilities of Agilent's time-of-flight (TOF) mass spectrometers and the unprecedented sample processing speed of RapidFire® technology, the instrument revolutionizes in vitro ADME analysis by eliminating the method development bottleneck in drug discovery.

From Evident Corporation - Life Sciences 20 May 2010

Employers must assess current and future retiree prescription benefit options: Medco Health Solutions

As the nation's healthcare system begins to understand and address the impact of the recently enacted healthcare reform legislation, employers must assess their current and future retiree prescription benefit options, according to executives from Medco Health Solutions, Inc. speaking to more than 700 clients at Medco's annual Drug Trend Symposium.

20 May 2010

Collegium Pharmaceutical receives Notice of Allowance from USPTO for DETERx technology

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that it has received Notice of Allowance from the U.S. Patent and Trademark Office for its patent application "Abuse-Deterrent Drug Formulations", US Patent Application Number 11/149,867. The Notice of Allowance is the USPTO's official communication that the Company's application has successfully completed examination and that a patent will be issued.

20 May 2010

ForeverGreen Worldwide reports over 300% growth in first-quarter 2010 cash flow from operations

ForeverGreen Worldwide Corp., a manufacturer and distributor of all natural whole foods, today announced that its 2010 Q1 filing reports positive cash flow from operations.

20 May 2010

BioLife Solutions first-quarter revenue up 36% to $513,000

BioLife Solutions, Inc., announced today that Chairman and Chief Executive Officer Mike Rice issued the following letter to shareholders providing a general corporate update.

20 May 2010

PurGenesis completes development of novel anti-aging cosmeceutical products

PurGenesis Technologies, Inc. today announced the successful completion of the development of a unique line of anti-aging cosmeceutical products. The product line consists of three unique, anti-aging formulations: Day Cream, Night Cream and Eye Cream.

20 May 2010

Safeway Step receives 2010 Caregiver Friendly Award

Safeway Safety Step, LLC has recently been recognized by two national organizations renowned for their service and education in aiding caregivers and seniors remaining in their homes or aging in place. The Safeway Step is a product and installation method designed to provide an economical renovation option for individuals and facilities interested in easier access into the bathtub area.

20 May 2010

Dispelling misconceptions associated with anaesthesia reduce patient anxiety before surgery

Eight-five per cent of patients who took part in a survey shortly after day surgery said that they had been anxious about receiving a general anaesthetic, according to research in the May issue of the Journal of Advanced Nursing.

20 May 2010

3rd Annual Disability Leadership and Policy Summit to commemorate 20th Anniversary of the ADA

United Spinal Association will host its 3rd Annual Disability Leadership and Policy Summit commemorating the 20th Anniversary of the Americans with Disabilities Act on June 2nd at Hofstra University in Hempstead, New York.

20 May 2010

EPFL develops flowing 3D model of cardiovascular system that predicts heart attacks

The supercomputer Cadmos, installed at the Ecole Polytechnique Fédérale de Lausanne (EPFL) in August of 2009, has bared one of its first fruits: the Laboratory of Multiscale Modeling of Materials has recently developed a computer program the accurately models the complex system of blood flow in the heart for individuals at an unheard-of precision of ten millionths of a meter or ten microns.

20 May 2010

Phase 1/2 clinical trial data of Oncophage for recurrent high-grade glioma

Antigenics today announced that data from a multi-center Phase 1/2 clinical trial of Oncophage (vitespen) for recurrent high-grade glioma (brain cancer) was presented at the International Conference on Brain Tumor Research and Therapy. The study was conducted by the Brain Tumor Research Center at the University of California, San Francisco.

20 May 2010

AACN and Elsevier/MC Strategies announce Critical Care Pharmacology online nursing course

Elsevier/MC Strategies, a pioneer in providing e-learning solutions to more than 1,300 healthcare organizations, has partnered with the American Association of Critical-Care Nurses (AACN) to develop a series of online nursing courses. Today, AACN and Elsevier/MC Strategies announced the first course in this series: AACN Critical Care Pharmacology.

20 May 2010

Cato Research to provide etrials EDC solution through Merge Healthcare's technology transfer program

Merge Healthcare, a leading Health IT solutions provider, announced today that it was selected by Cato Research Ltd. to provide the proprietary etrials EDC solution through Merge's technology transfer program. This new agreement expands Merge's partnership with CATO to provide additional technology for clinical trials management, as well as extending the relationship for an additional five years.

20 May 2010

Vanderbilt University orders Bruker's AVANCE III 900 US2 NMR spectrometer

Bruker, the leader in analytical magnetic resonance instrumentation, announces a major multi-systems NMR order from Vanderbilt University, including an ultra-high field AVANCE™ III 900 US2 NMR spectrometer. This purchase was made possible in large part by the American Recovery and Reinvestment Act. Vanderbilt will use these NMR instruments for a broad range of biophysical and structural analyses in biomedical research, as well as for cancer drug discovery using fragment-based approaches and structure-based drug design.

20 May 2010

Prolifiq conducts workshop on driving sales activity with systematic adherance to regulations

As the medical device industry gathers at Sales and Marketing Excellence 2010, Prolifiq, the leading provider of Sales Content Management software, offers medical device companies a solution to promote and sell in this highly regulated environment.

20 May 2010

GFCF diet shows no significant benefits on the behavior of children with ASD: Study

A popular belief that specific dietary changes can improve the symptoms of children with autism was not supported by a tightly controlled University of Rochester study, which found that eliminating gluten and casein from the diets of children with autism had no impact on their behavior, sleep or bowel patterns.

20 May 2010

STAAR Surgical receives CE Mark approval for product improvements to Visian Implantable Collamer Lens

STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced CE Mark approval for a range of product improvements to the Company's Visian Implantable Collamer® Lens (ICL™) that more than doubles the current Visian addressable market in Europe.

20 May 2010

NeuroTherapeutics Pharma closes $43 million Series B financing round

NeuroTherapeutics Pharma, Inc. (NTP), a biopharmaceutical company focused on developing novel therapies for central nervous system (CNS) disorders, announced today that it closed a $43 million Series B financing. New investors include Fidelity Biosciences, MPM Capital and SR One, who co-led the transaction, and Pfizer, Inc. Existing investors Novo Ventures and Thomas McNerney & Partners also participated in the round.

20 May 2010

Patterson's consolidated sales for fourth-quarter fiscal 2010 up 4%

Patterson Companies, Inc. today reported consolidated sales of $812,762,000 for the fourth quarter of fiscal 2010 ended April 24, an increase of 4% from $779,884,000 in the year-earlier quarter. Internal growth accounted for 1% of the fourth quarter sales increase, with acquisitions and foreign currency adjustments accounting for the balance.

20 May 2010

Encision fourth-quarter net sales increase 3.6% to $3.19 million

Encision Inc., a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, reported its financial results for its fourth quarter and fiscal year ended March 31, 2010.

20 May 2010

Medical News

BIOCIUS and Agilent launch RF360 High Resolution System for high-throughput screening of in vitro ADME assays

Employers must assess current and future retiree prescription benefit options: Medco Health Solutions

Collegium Pharmaceutical receives Notice of Allowance from USPTO for DETERx technology

ForeverGreen Worldwide reports over 300% growth in first-quarter 2010 cash flow from operations

BioLife Solutions first-quarter revenue up 36% to $513,000

PurGenesis completes development of novel anti-aging cosmeceutical products

Safeway Step receives 2010 Caregiver Friendly Award

Dispelling misconceptions associated with anaesthesia reduce patient anxiety before surgery

3rd Annual Disability Leadership and Policy Summit to commemorate 20th Anniversary of the ADA

EPFL develops flowing 3D model of cardiovascular system that predicts heart attacks

Phase 1/2 clinical trial data of Oncophage for recurrent high-grade glioma

AACN and Elsevier/MC Strategies announce Critical Care Pharmacology online nursing course

Cato Research to provide etrials EDC solution through Merge Healthcare's technology transfer program

Vanderbilt University orders Bruker's AVANCE III 900 US2 NMR spectrometer

Prolifiq conducts workshop on driving sales activity with systematic adherance to regulations

GFCF diet shows no significant benefits on the behavior of children with ASD: Study

STAAR Surgical receives CE Mark approval for product improvements to Visian Implantable Collamer Lens

NeuroTherapeutics Pharma closes $43 million Series B financing round

Patterson's consolidated sales for fourth-quarter fiscal 2010 up 4%

Encision fourth-quarter net sales increase 3.6% to $3.19 million

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News